Italian risk-sharing agreements on drugs : are they worthwhile?
Year of publication: |
2015
|
---|---|
Authors: | Garattini, Livio ; Curto, Alessandro ; Van de Vooren, Katelijne |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 16.2015, 1, p. 1-3
|
Subject: | Italien | Italy | Arzneimittel | Pharmaceuticals | Drogenkonsum | Drug consumption | Droge | Drug |
-
Festa, Giuseppe, (2021)
-
Csete, Joanne, (2024)
-
Wilson, Anne V., (2022)
- More ...
-
Pricing of forthcoming therapies for hepatitis C in Europe : beyond cost-effectiveness?
Van de Vooren, Katelijne, (2015)
-
Western European Markets for biosimilar and generic drugs : worth differentiating : Editorial
Garattini, Livio, (2015)
-
Editorial: market approval for drugs in the EU : time to change direction?
Curto, Alessandro, (2017)
- More ...